Testing effectiveness (Phase 2)Looking for participantsNCT05778188
What this trial is testing
Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia
Who this might be right for
Hypoxic-Ischemic Encephalopathy
ReAlta Life Sciences, Inc. 42